UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Novel Biomarkers of Acute Kidney Toxicity

Clinical pharmacology and therapeutics, 2009-11, Vol.86 (5), p.490-496

2009

Link zum Volltext

Verfügbarkeit prüfen

The selective FXR agonist EYP001 is well tolerated in healthy subjects and has additive anti-HBV effect with nucleoside analogues in HepaRG cells

Journal of hepatology, 2017, Vol.66 (1), p.S690-S690

2017

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Approach to Preclinical and Clinical Safety Biomarker Qualification Incorporating Bradford Hill's Principles of Causality Association

Clinical pharmacology and therapeutics, 2010-08, Vol.88 (2), p.260-262

2010

Link zum Volltext

Verfügbarkeit prüfen

Rationale for the development of sandimmune neoral

Transplantation proceedings, 1994-10, Vol.26 (5), p.2925-2927

1994

Link zum Volltext

Verfügbarkeit prüfen

FRI-286 - First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001

Journal of hepatology, 2018-04, Vol.68, p.S488-S489

2018

Link zum Volltext

Verfügbarkeit prüfen

First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001

Journal of hepatology, 2018-04, Vol.68, p.S488-S489

2018

Link zum Volltext

Verfügbarkeit prüfen

SAT-158 - The selective FXR agonist EYP001 is well tolerated in healthy subjects and has additive anti-HBV effect with nucleoside analogues in HepaRG cells

Journal of hepatology, 2017, Vol.66 (1), p.S690-S690

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of cyclosporine in monkeys after oral and intramuscular administration: relation to efficacy in kidney allografting

Transplant international, 2001-09, Vol.14 (5), p.320-328

2001

Link zum Volltext

Verfügbarkeit prüfen

Enteral absorption of octreotide: absorption enhancement by polyoxyethylene‐24‐cholesterol ether

British journal of pharmacology, 1993-02, Vol.108 (2), p.298-303

1993

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of the oral absorption of cyclosporin in man

British journal of clinical pharmacology, 1992-07, Vol.34 (1), p.60-64

1992

Link zum Volltext

Verfügbarkeit prüfen

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR

Journal of controlled release, 1999-05, Vol.59 (2), p.197-205

1999

Link zum Volltext

Verfügbarkeit prüfen

Novel Biomarkers of Acute KidneyToxicity

Clinical pharmacology and therapeutics, 2009, Vol.86 (5), p.490-496

2009

Link zum Volltext

Verfügbarkeit prüfen

Enteral absorption of octreotide

British journal of pharmacology, 1992-04, Vol.105 (4), p.783-786

1992

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the rate of phagocytosis of orthorhombic cyclosporine A (CsA) and latex particles by alveolar macrophages from hamsters

Cellular and molecular life sciences : CMLS, 1997-09, Vol.53 (8), p.689-696

1997

Link zum Volltext

Verfügbarkeit prüfen

Quantification and visualization of the transport of octreotide, a somatostatin analogue, across monolayers of cerebrovascular endothelial cells

Pharmaceutical research, 1994-03, Vol.11 (3), p.442-448

1994

Link zum Volltext

Verfügbarkeit prüfen

Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of Somatostatin

Scandinavian journal of gastroenterology, 1986, Vol.21 (S119), p.54-64

1986

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the human cell line RPMI 2650 as an in vitro nasal model

Rhinology, 1995-12, Vol.33 (4), p.194-198

1995

Link zum Volltext

Verfügbarkeit prüfen

Neoral pharmacokinetics in cynomolgus monkeys : Relation to efficacy in renal allografting

Transplantation proceedings, 1996-12, Vol.28 (6), p.3142-3144

1996

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacodynamic analysis of octreotide in acromegalic patients

Clinical pharmacology and therapeutics, 2003-01, Vol.73 (1), p.95-106

2003

Link zum Volltext

Verfügbarkeit prüfen

Poly(alkyl cyanoacrylate) Nanocapsules as a Delivery System in the Rat for Octreotide, a Long-acting Somatostatin Analogue

Journal of pharmacy and pharmacology, 1997-10, Vol.49 (10), p.949-954

1997

Link zum Volltext

Verfügbarkeit prüfen

VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genes

Pharmaceutical research, 2005-10, Vol.22 (10), p.1597-1613

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the phagocytosis of two types of cyclosporin (SDZ OXL 400 and SDZ IMM 125) by alveolar macrophages from hamsters

Cell biology and toxicology, 1998-12, Vol.14 (6), p.411-418

1998

Link zum Volltext

Verfügbarkeit prüfen

In vitro tolerability of human nasal mucosa : histopathological and scanning electron-microscopic evaluation of nasal forms containing Sandostatin

Cell biology and toxicology, 1995-10, Vol.11 (5), p.295-301

1995

Link zum Volltext

Verfügbarkeit prüfen

Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits

Journal of pharmaceutical sciences, 2000-09, Vol.89 (9), p.1123-1133

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(48)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(25)
Animals
(23)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Pharmacology. Drug Treatments
(20)
Male
(18)
Pharmacology & Pharmacy
(14)
Humans
(13)
Rats
(12)
Octreotide - Pharmacokinetics
(9)
Octreotide
(7)
Drug-Related Side Effects And Adverse Reactions
(6)
Hormones. Endocrine System
(6)
Intestinal Absorption
(6)
Adult
(5)
Chemistry
(5)
Drug Toxicity And Drugs Side Effects Treatment
(5)
Female
(5)
Hormones - Pharmacokinetics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel Biomarkers of Acute Kidney Toxicity

The selective FXR agonist EYP001 is well tolerated in healthy subjects and has additive anti-HBV effect with nucleoside analogues in HepaRG cells

A Systematic Approach to Preclinical and Clinical Safety Biomarker Qualification Incorporating Bradford Hill's Principles of Causality Association

Rationale for the development of sandimmune neoral

FRI-286 - First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001

First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001

Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact

SAT-158 - The selective FXR agonist EYP001 is well tolerated in healthy subjects and has additive anti-HBV effect with nucleoside analogues in HepaRG cells

Pharmacokinetics of cyclosporine in monkeys after oral and intramuscular administration: relation to efficacy in kidney allografting

Enteral absorption of octreotide: absorption enhancement by polyoxyethylene‐24‐cholesterol ether

Enhancement of the oral absorption of cyclosporin in man

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR

Novel Biomarkers of Acute KidneyToxicity

Enteral absorption of octreotide

Comparison of the rate of phagocytosis of orthorhombic cyclosporine A (CsA) and latex particles by alveolar macrophages from hamsters

Quantification and visualization of the transport of octreotide, a somatostatin analogue, across monolayers of cerebrovascular endothelial cells

Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of Somatostatin

Evaluation of the human cell line RPMI 2650 as an in vitro nasal model

Neoral pharmacokinetics in cynomolgus monkeys : Relation to efficacy in renal allografting

Population pharmacodynamic analysis of octreotide in acromegalic patients

Poly(alkyl cyanoacrylate) Nanocapsules as a Delivery System in the Rat for Octreotide, a Long-acting Somatostatin Analogue

VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genes

Comparison of the phagocytosis of two types of cyclosporin (SDZ OXL 400 and SDZ IMM 125) by alveolar macrophages from hamsters

In vitro tolerability of human nasal mucosa : histopathological and scanning electron-microscopic evaluation of nasal forms containing Sandostatin

Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits

Suchergebnisse filtern